Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2022-09-30
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia
NCT00999973
The Effect of Mitomycin C on Corneal Haze and Scarring After Corneal Crosslinking in Keratoconus Patients
NCT04811924
Mitomycin-c Application for PRK
NCT01504282
Corneal WFG Versus AF Trans PRK in Myopic Patients With High Corneal HOA
NCT03786861
Anterior Stromal Changes After PRK by Using Intraoperative Mitomicin C
NCT00599950
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TransEpi single step PRK
Transepithelial PRK/MMC
transepithelial photorefractive keratectomy (PRK) and mitomycin C addition
alcohol assisted PRK
Alcohol-Assisted PRK/MMC
photorefractive keratectomy (PRK) assisted by alchol and mitomycin C addition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transepithelial PRK/MMC
transepithelial photorefractive keratectomy (PRK) and mitomycin C addition
Alcohol-Assisted PRK/MMC
photorefractive keratectomy (PRK) assisted by alchol and mitomycin C addition
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary myopia or compound myopic astigmatism.
* Preoperative manifest refraction spherical equivalent (MRSE) within the range of -1.0 to 8 D
* Stable refractive error for at least 12 months before the surgery.
* Contact lens discontinuation for at least 3 weeks.
* Estimated corneal stromal bed thickness of more than 300mm at the thinnest point
Exclusion Criteria
* Previous ocular surgery
* Any diagnosed ocular disease
* History of ocular trauma
17 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ehab tharwat
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ehab tharwat
Damietta, New Damietta, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mitomycin-C
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.